Knowles Corporation introduced its new ATT A-Series Attenuators, designed for compact, rugged, and cost-effective RF solutions with performance from DC to 20 GHz. These attenuators use precision thin-film technology to deliver stable electrical performance, high power handling, and excellent attenuation accuracy in a small surface mount package. The product targets applications in defense, aerospace, wireless infrastructure, and satellite communications, offering easy integration and improved reliability. This launch strengthens Knowles' position as a comprehensive supplier of high-performance RF components.
Knowles Corporation's new A-Series Attenuators are the focus, with Pluang's Technology sector market data as context. As of Sep 30, 2026 19:13 WIB, out of 150 priced US Technology stocks tradable on Pluang, 62 rose and 77 fell. Notable movers include Veritone Inc (VERI) at USD 1.30 with a 1-day change of -1.52%, Applovin Corporation (APP) at USD 301.28 with -1.43%, and Strategy Inc. (MSTR) at USD 156.80 with +1.38%. The most notable figure is the 78% sell order activity for Applovin Corporation.
Clean Harbors Co-CEO Gerstenberg has sold 2,500 shares of the company. Insider sales like this can indicate personal financial decisions or views on the company’s stock value. Investors often watch such moves for clues about company prospects, though...
A recent survey by Summer's Eve reveals that while 63% of U.S. women feel more comfortable discussing intimate health than five years ago, over half still avoid these conversations due to embarrassment. The research highlights a cultural shift toward...
Q32 Bio announced positive 36-week results from its Phase 2a SIGNAL-AA trial of bempikibart for severe alopecia areata, showing meaningful hair regrowth and durable responses even after 16 weeks off treatment. The drug demonstrated a favorable safety...
Lion Group Holding Ltd. sold all its Solana holdings and part of its Bitcoin on September 29, 2026, to buy around 38,102 additional Hyperliquid (HYPE) tokens, increasing its total HYPE holdings to about 232,900 tokens valued at $20.1 million. This mo...
Fulcrum Therapeutics announced the discontinuation of its pociredir program for sickle cell disease after the FDA raised serious concerns about cancer risks linked to the drug class. This followed findings of high rates of secondary blood cancers wit...
